VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
In summary, the ligand for c-kit has biological synergy both in vivo and in<br />
vitro with G-CSF. In vivo, the effects of G-CSF on the absolute leukocyte count<br />
and on the numbers of circulating progenitor cells are markedly enhanced by<br />
the simultaneous administration of rhSCF, but not by prior administration of<br />
rhSCF. In vitro, rhSCF enhances the proliferation of CFC and precursors of CFC<br />
that are stimulated by G-CSF. It is possible that such synergistic interactions may<br />
have clinical importance if circulation of transplantable "stem" cells also is enhanced<br />
or if stem cells in marrow are increased. Further studies to examine the<br />
in vivo synergy of rhSCF with other hematopoietic growth factors may provide<br />
novel therapeutic approaches.<br />
REFERENCES<br />
1. Zsebo KM, Wypych J, et al: Identification, purification, and biological characterization<br />
of hematopoietic stem cell factor from buffalo rat liver-conditioned medium.<br />
Cell 63:195-201,1990.<br />
2. Williams DE, Eisenman J, et al: Identification of a ligand for the c-kit proto-oncogene.<br />
Cell 63:167-174,1990.<br />
3. Huang E, Nocka K, et al: The hematopoietic growth factor KL is encoded at the SI<br />
locus and is the ligand of the c-lit receptor, the gene product of the W locus. Cell<br />
63:225-233,1990.<br />
4. Witte ON: Steel locus defines new multipotent growth factor. Cell 63:5-6,1990.<br />
5. McNiece IK, Langley KE, et al: Recombinant human stem cell factor synergizes with<br />
GM-CSF, G-CSF, IL-3, and epo to stimulate human progenitor cells of the myeloid<br />
and erythroid lineages. Exp Hematol 19:226-231,1991.<br />
6. Carow CE, Hangoc G, et al. Mast cell growth factor (c-kit ligand) supports the<br />
growth of human multipotential progenitor cells with a high replating efficiency.<br />
Blood 78:2216-2221,1991.<br />
7. Bernstein ID, Andrews RG, et al: Recombinant human stem cell factor enhances the<br />
formation of colonies by CD34+ and CD34+ lin- cells, and the generation of colonyforming<br />
cell progeny from CD34+ lin- cells cultured with IL-3, G-CSF, or GM-CSF.<br />
Blood 77:2316-2321,1991.<br />
8. Zsebo KM, Smith KA, et al: Biological characteristics of recombinant rat and human<br />
stem cell factor, in Blood Cell Growth Factors: Their Present and Future Use in<br />
Hematology and Oncology, Murphy MJ (ed), AlphaMed Press, Dayton, OH, 1991,<br />
pl94-203.<br />
9. Andrews RG, Knitter GH, et al: Recombinant human stem cell factor, a c-kit ligand,<br />
stimulates hematopoiesis in primates. Blood 78:1975-1980,1991.<br />
10. Andrews RG, Bartelmez SH, et al: A c-kit ligand, recombinant human stem cell<br />
factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in<br />
blood and marrow of baboons. Blood 80:920-927,1992.<br />
11. Briddell R, Hartley C, et al: The role of stem cell factor in mobilization of peripheral<br />
blood progenitor cells (PBPC) with marrow repopulating ability in mice. Blood<br />
80(Suppl l):12a, 1992 (abstract).<br />
12. Molineux G, Migdalska A, et al: The effects on hematopoiesis of recombinant stem<br />
cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination<br />
with granulocyte colony-stimulating factor. Blood 78:961-966,1991.<br />
13. Sheridan WP, Begley G, et al: Effect of peripheral blood progenitor cells mobilized<br />
by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet<br />
339:640-644,1992.<br />
14. Molineux G, Pojda Z, et al. <strong>Transplantation</strong> potential of peripheral blood stem cells<br />
induced by granulocyte colony-stimulating factor. Blood 76:2153-2158,1990.<br />
230 SIXTH INTERNATIONAL SYMPOSIUM ON AUTOLOGOUS BONE MARROW TRANSPLANTATION